Samsung Medical Center
π°π·South Korea
- Country
- π°π·South Korea
- Ownership
- Subsidiary
- Established
- 1994-01-01
- Employees
- 501
- Market Cap
- -
Use of Perfusion Index Change as a Predictor of Hypotension During Propofol Sedation in Adult Patients Undergoing Hip Surgery Under Spinal Anesthesia: A Prospective Observational Study
Completed
- Conditions
- HypotensionSpinal Anesthetics Causing Adverse Effects in Therapeutic Use
- Interventions
- Other: Observation
- First Posted Date
- 2018-06-14
- Last Posted Date
- 2022-08-23
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 39
- Registration Number
- NCT03556969
- Locations
- π°π·
Samsung Medical Center, Sungkyunkwan University, School of Medicine, Seoul, Korea, Republic of
Safety and Effectiveness of Low Dose Edoxaban in Patients With NVAF
- Conditions
- Atrial Fibrillation
- First Posted Date
- 2018-06-13
- Last Posted Date
- 2018-06-13
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 2562
- Registration Number
- NCT03554837
- Locations
- π°π·
Samsung Medical Center, Seoul, Korea, Republic of
Effects of Dietary Fiber on Glucose Control in Subjects With Type 2 Diabetes Mellitus
Phase 4
Completed
- Conditions
- Diabetes Mellitus, Type 2
- Interventions
- Drug: Agiocur Pregranules
- First Posted Date
- 2018-06-12
- Last Posted Date
- 2018-06-12
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 14
- Registration Number
- NCT03552991
Early Rehabilitation After Immediate Reconstruction With TEI in Breast Cancer Patients
Completed
- Conditions
- Breast Cancer
- First Posted Date
- 2018-05-30
- Last Posted Date
- 2018-05-30
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 115
- Registration Number
- NCT03541161
- Locations
- π°π·
Samsung Medical Center, Seoul, Gangnam-gu, Korea, Republic of
Genetic and Histopathologic Characteristics of Interstitial Cystitis
Completed
- Conditions
- Interstitial Cystitis
- Interventions
- Genetic: bladder tissue of Interstitial Cystitis and normal bladder tissue
- First Posted Date
- 2018-05-14
- Last Posted Date
- 2024-10-29
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 14
- Registration Number
- NCT03523559
- Locations
- π°π·
Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea, Republic of
Effects of Muscle Relaxation on Cognitive Function in Patients With Mild Cognitive Impairment and Early Stage Dementia.
Not Applicable
- Conditions
- Mild Cognitive ImpairmentAlzheimer Dementia
- Interventions
- Device: Muscle relaxation using full body massage machine
- First Posted Date
- 2018-04-24
- Last Posted Date
- 2019-03-14
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 60
- Registration Number
- NCT03507192
- Locations
- π°π·
Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea, Republic of
Prediction of WMH in Migraine Using a BOLD-CVR Map
- Conditions
- Migraine
- Interventions
- Diagnostic Test: BOLD MRI
- First Posted Date
- 2018-04-11
- Last Posted Date
- 2019-04-10
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 74
- Registration Number
- NCT03494673
- Locations
- π°π·
Samsung Medical Center, Seoul, Korea, Republic of
App-based Cognitive Training at Home
Not Applicable
- Conditions
- Healthy Volunteers, Aged
- Interventions
- Behavioral: Multidisciplinary prevention
- First Posted Date
- 2018-04-11
- Last Posted Date
- 2019-01-30
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 400
- Registration Number
- NCT03494699
- Locations
- π°π·
Gangnam Dementia Center, Seoul, Korea, Republic of
Longitudinal Changes of Brain Functional Connectivity in Migraine
- Conditions
- Migraine
- Interventions
- Diagnostic Test: resting-state functional MRI
- First Posted Date
- 2018-04-04
- Last Posted Date
- 2020-03-20
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 100
- Registration Number
- NCT03487978
- Locations
- π°π·
Samsung Medical Center, Seoul, Korea, Republic of
Bortezomib/Dexamethasone Therapy in Patients With Relapsed and/or Refractory Cutaneous T-cell Lymphoma
Phase 2
Completed
- Conditions
- Relapsed and/or Refractory Cutaneous T-cell Lymphoma
- Interventions
- Drug: bortezomib/dexamethasone
- First Posted Date
- 2018-04-03
- Last Posted Date
- 2020-10-26
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 32
- Registration Number
- NCT03487133
- Locations
- π°π·
Samsung medical center, Seoul, Gang Nam, Korea, Republic of
Β© Copyright 2025. All Rights Reserved by MedPath